| Product Code: ETC066705 | Publication Date: Jun 2023 | Updated Date: Jun 2026 | Product Type: Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
The Malaysia Infectious Disease Point-of-care Testing Market was estimated at USD 262 Million in 2025 and is projected to reach USD 343 Million by 2032, growing at a CAGR of 3.9% from 2026 to 2032. This growth trajectory is underpinned by the rising demand for rapid diagnosis and treatment of infectious diseases, particularly in the wake of increased prevalence of ailments such as HIV, hepatitis B, tuberculosis, and malaria. The growing emphasis on preventive healthcare and early disease detection among the Malaysian population further fuels the uptake of point-of-care testing solutions.
This graph highlights how the Malaysia Infectious Disease Point-of-care Testing Market has steadily grown over the years, supported by major growth factors.

The table below presents the year‑wise growth rates along with the key drivers influencing the market
| Year | Growth Rate | Major Drivers |
| 2021 | -2.7% | Expansion of manufacturing activities |
| 2022 | 4.5% | Rapid growth in telecom and data center sectors |
| 2023 | 8.8% | Growing urbanization and commercial development |
| 2024 | 4.4% | Expansion of commercial construction activities |
| 2025 | 5.4% | Increasing industrial infrastructure investments |
| 2026 | 5.2% | Expansion of commercial construction activities |
| 2027 | 4.9% | Increasing industrial infrastructure investments |
| 2028 | 5.1% | Growing urbanization and commercial development |
| 2029 | 4.9% | Growing renewable energy integration projects |
| 2030 | 5.1% | Expansion of transportation and logistics networks |
| 2031 | 4.9% | Growing renewable energy integration projects |
| 2032 | 5.0% | Expansion of transportation and logistics networks |
Note - Market size estimations and growth projections presented in this report are based on 6Wresearch’s advanced forecasting approach, validated with industry datasets as of June 2026.
The Malaysia Infectious Disease Point-of-care Testing Market has seen remarkable momentum driven by a heightened awareness of infectious diseases and the need for immediate diagnostic solutions. Looking ahead, the market is set to flourish as technological advancements and enhanced product offerings enter the landscape, promising to improve the accuracy and efficiency of testing methods.
In recent years, government initiatives aimed at early detection of health conditions have emphasized the importance of point-of-care testing. As the healthcare sector continues to prioritize rapid response capabilities, the market is poised for sustained growth, attracting attention from investors and healthcare providers alike.
Despite the positive growth outlook, several restraints could impede the full potential of the Malaysia Infectious Disease Point-of-care Testing Market. One significant challenge is the high cost of advanced diagnostic devices, which may limit accessibility in rural and underdeveloped areas. Additionally, variations in regulatory standards can create hurdles for manufacturers aiming to introduce new technologies. The need for continual training and education to ensure proper utilization of these testing devices is also a limiting factor, necessitating ongoing investment in workforce development.
A number of trends are currently shaping the Malaysia Infectious Disease Point-of-care Testing Market. Notably, there is a marked shift towards integrated diagnostic solutions that combine multiple tests into a single platform, enhancing efficiency and user experience. Additionally, mobile health applications are becoming increasingly popular, enabling individuals to access testing services remotely. The emphasis on personalized medicine is also driving demand for point-of-care tests that deliver tailored treatment options based on individual health profiles.
The future holds significant opportunities for growth within the Malaysia Infectious Disease Point-of-care Testing Market. Investment in research and development can lead to innovative testing solutions that address current gaps in diagnosis. Furthermore, partnerships between public health organizations and private sector players can facilitate the implementation of wide-scale testing initiatives, particularly in underserved areas. The ongoing pandemic has also highlighted the critical need for rapid testing, indicating a sustained market demand for point-of-care solutions.
The Malaysian government has been proactive in promoting the importance of early detection and treatment of infectious diseases through various initiatives. Increased public spending on healthcare, alongside the introduction of programs designed to raise awareness about preventive measures, has positioned point-of-care testing as a crucial element of the national health strategy. Additionally, incentives for research and development in healthcare technology are fostering innovation in the point-of-care testing sector.
Looking ahead to the 2026-2032 timeframe, the Malaysia Infectious Disease Point-of-care Testing Market is expected to evolve significantly. Enhanced regulatory frameworks will likely streamline the introduction of innovative diagnostic tools, and continued investments in healthcare technology will improve testing accuracy and accessibility. Additionally, the market will benefit from the increasing integration of artificial intelligence and data analytics in point-of-care testing, further enhancing decision-making and patient outcomes.
In the period between May 2025 and June 2026, the industry has seen a surge in the introduction of novel point-of-care testing devices designed to address a broader range of infectious diseases. Collaborations among healthcare stakeholders have strengthened, aimed at enhancing testing accessibility in rural regions. Furthermore, public health campaigns emphasizing the importance of rapid testing have garnered increased attention, setting the stage for further market expansion.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Malaysia Infectious Disease Point-of-care Testing Market Overview |
3.1 Malaysia Country Macro Economic Indicators |
3.2 Malaysia Infectious Disease Point-of-care Testing Market Revenues & Volume, 2022 & 2032F |
3.3 Malaysia Infectious Disease Point-of-care Testing Market - Industry Life Cycle |
3.4 Malaysia Infectious Disease Point-of-care Testing Market - Porter's Five Forces |
3.5 Malaysia Infectious Disease Point-of-care Testing Market Revenues & Volume Share, By Applications, 2022 & 2032F |
3.6 Malaysia Infectious Disease Point-of-care Testing Market Revenues & Volume Share, By Technologies, 2022 & 2032F |
3.7 Malaysia Infectious Disease Point-of-care Testing Market Revenues & Volume Share, By End-users, 2022 & 2032F |
4 Malaysia Infectious Disease Point-of-care Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Malaysia Infectious Disease Point-of-care Testing Market Trends |
6 Malaysia Infectious Disease Point-of-care Testing Market, By Types |
6.1 Malaysia Infectious Disease Point-of-care Testing Market, By Applications |
6.1.1 Overview and Analysis |
6.1.2 Malaysia Infectious Disease Point-of-care Testing Market Revenues & Volume, By Applications, 2022-2032F |
6.1.3 Malaysia Infectious Disease Point-of-care Testing Market Revenues & Volume, By Tropical Disease, 2022-2032F |
6.1.4 Malaysia Infectious Disease Point-of-care Testing Market Revenues & Volume, By Liver Disease, 2022-2032F |
6.1.5 Malaysia Infectious Disease Point-of-care Testing Market Revenues & Volume, By Respiratory Disease, 2022-2032F |
6.1.6 Malaysia Infectious Disease Point-of-care Testing Market Revenues & Volume, By Sexual Disorders, 2022-2032F |
6.1.7 Malaysia Infectious Disease Point-of-care Testing Market Revenues & Volume, By Others, 2022-2032F |
6.2 Malaysia Infectious Disease Point-of-care Testing Market, By Technologies |
6.2.1 Overview and Analysis |
6.2.2 Malaysia Infectious Disease Point-of-care Testing Market Revenues & Volume, By Lateral Flow, 2022-2032F |
6.2.3 Malaysia Infectious Disease Point-of-care Testing Market Revenues & Volume, By Flow-through, 2022-2032F |
6.2.4 Malaysia Infectious Disease Point-of-care Testing Market Revenues & Volume, By Agglutination Assays, 2022-2032F |
6.2.5 Malaysia Infectious Disease Point-of-care Testing Market Revenues & Volume, By Solid Phase, 2022-2032F |
6.3 Malaysia Infectious Disease Point-of-care Testing Market, By End-users |
6.3.1 Overview and Analysis |
6.3.2 Malaysia Infectious Disease Point-of-care Testing Market Revenues & Volume, By Diagnostic Laboratories, 2022-2032F |
6.3.3 Malaysia Infectious Disease Point-of-care Testing Market Revenues & Volume, By Hospitals, 2022-2032F |
6.3.4 Malaysia Infectious Disease Point-of-care Testing Market Revenues & Volume, By Home-care Settings, 2022-2032F |
6.3.5 Malaysia Infectious Disease Point-of-care Testing Market Revenues & Volume, By Others, 2022-2032F |
7 Malaysia Infectious Disease Point-of-care Testing Market Import-Export Trade Statistics |
7.1 Malaysia Infectious Disease Point-of-care Testing Market Export to Major Countries |
7.2 Malaysia Infectious Disease Point-of-care Testing Market Imports from Major Countries |
8 Malaysia Infectious Disease Point-of-care Testing Market Key Performance Indicators |
9 Malaysia Infectious Disease Point-of-care Testing Market - Opportunity Assessment |
9.1 Malaysia Infectious Disease Point-of-care Testing Market Opportunity Assessment, By Applications, 2022 & 2032F |
9.2 Malaysia Infectious Disease Point-of-care Testing Market Opportunity Assessment, By Technologies, 2022 & 2032F |
9.3 Malaysia Infectious Disease Point-of-care Testing Market Opportunity Assessment, By End-users, 2022 & 2032F |
10 Malaysia Infectious Disease Point-of-care Testing Market - Competitive Landscape |
10.1 Malaysia Infectious Disease Point-of-care Testing Market Revenue Share, By Companies, 2025 |
10.2 Malaysia Infectious Disease Point-of-care Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here